Your Health. Your Family. Your Choice.
Administered by: Other Purchased by: ?
Life Threatening? No
Write-up: BELL''S PALSY; BLOOD CLOT; GUILLAIN BARRE SYNDROME; ANAPHYLAXIS; This spontaneous report received from a patient via a company representative (other manufacturer Pfizer ) concerned multiple patients. The patient height and weight was not reported .No past medical history or concurrent conditions were reported.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported)frequency one total , dose, start therapy date were not reported for prophylactic vaccination.The batch no was not reported ,The Company is unable to performed follow up to request batch /Lot numbers. No concomitant medications were reported. On an unspecified date, the subject experienced bell''s palsy, blood clot, guillain barre syndrome, and anaphylaxis. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the bell''s palsy, blood clot, guillain barre syndrome and anaphylaxis was not reported. This report was serious (Other Medically Important Condition).; Sender''s Comments: V0. 20210556206-COVID-19 VACCINE AD26.COV2.S. Bell''s palsy, Blood clot, Guillain Barre syndrome. This events is considered unassessable. The events has an unknown/unclear temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the events. 20210556206-COVID-19 VACCINE AD26.COV2.S. Anaphylaxis. This event is labeled per RSI and is therefore considered potentially related.
Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166